More recently, MYC/BCL6 rearrangement lymphomas have been reported to be more frequently CD10 negative with IRF4/MUM1 positive, and cytogenetically less complex than MYC/BCL2 rearrangement lymphomas [93]. Here, IRF4 is linked to lymphoma.